95 related articles for article (PubMed ID: 35897761)
1. ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Garnham R; Geh D; Nelson R; Ramon-Gil E; Wilson L; Schmidt EN; Walker L; Adamson B; Buskin A; Hepburn AC; Hodgson K; Kendall H; Frame FM; Maitland N; Coffey K; Strand DW; Robson CN; Elliott DJ; Heer R; Macauley M; Munkley J; Gaughan L; Leslie J; Scott E
Commun Biol; 2024 Mar; 7(1):276. PubMed ID: 38448753
[TBL] [Abstract][Full Text] [Related]
2. Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum.
Girigoswami K; Pallavi P; Girigoswami A
Drug Deliv; 2023 Dec; 30(1):2284684. PubMed ID: 37990530
[TBL] [Abstract][Full Text] [Related]
3. Targeting aberrant sialylation and fucosylation in prostate cancer cells using potent metabolic inhibitors.
Orozco-Moreno M; Visser EA; Hodgson K; Hipgrave Ederveen AL; Bastian K; Goode EA; Öztürk Ö; Pijnenborg JFA; Eerden N; Moons SJ; Rossing E; Wang N; de Haan N; Büll C; Boltje TJ; Munkley J
Glycobiology; 2023 Dec; 33(12):1155-1171. PubMed ID: 37847613
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Scott E; Hodgson K; Calle B; Turner H; Cheung K; Bermudez A; Marques FJG; Pye H; Yo EC; Islam K; Oo HZ; McClurg UL; Wilson L; Thomas H; Frame FM; Orozco-Moreno M; Bastian K; Arredondo HM; Roustan C; Gray MA; Kelly L; Tolson A; Mellor E; Hysenaj G; Goode EA; Garnham R; Duxfield A; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Bogdan D; Westaby D; Fowler G; Flohr P; Yuan W; Sharp A; de Bono J; Maitland NJ; Wisnovsky S; Bertozzi CR; Heer R; Guerrero RH; Daugaard M; Leivo J; Whitaker H; Pitteri S; Wang N; Elliott DJ; Schumann B; Munkley J
Oncogene; 2023 Mar; 42(12):926-937. PubMed ID: 36725887
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein folding and the role of EDEM1, EDEM2 and EDEM3 in degradation of folding-defective glycoproteins.
Olivari S; Molinari M
FEBS Lett; 2007 Jul; 581(19):3658-64. PubMed ID: 17499246
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation is a global target for androgen control in prostate cancer cells.
Munkley J
Endocr Relat Cancer; 2017 Mar; 24(3):R49-R64. PubMed ID: 28159857
[TBL] [Abstract][Full Text] [Related]
7. Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer.
Scott E; Garnham R; Cheung K; Duxfield A; Elliott DJ; Munkley J
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897761
[TBL] [Abstract][Full Text] [Related]
8. ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing α-mannosidase-like protein 3 (EDEM3).
Yu S; Ito S; Wada I; Hosokawa N
J Biol Chem; 2018 Jul; 293(27):10663-10674. PubMed ID: 29784879
[TBL] [Abstract][Full Text] [Related]
9. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming.
Hirao K; Natsuka Y; Tamura T; Wada I; Morito D; Natsuka S; Romero P; Sleno B; Tremblay LO; Herscovics A; Nagata K; Hosokawa N
J Biol Chem; 2006 Apr; 281(14):9650-8. PubMed ID: 16431915
[TBL] [Abstract][Full Text] [Related]
10. EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning.
Manica G; Ghenea S; Munteanu CVA; Martin EC; Butnaru C; Surleac M; Chiritoiu GN; Alexandru PR; Petrescu AJ; Petrescu SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671632
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Mannosidase Assay of EDEMs: ER Degradation-Enhancing α-Mannosidase-Like Proteins.
Hosokawa N
Methods Mol Biol; 2020; 2132():151-158. PubMed ID: 32306323
[TBL] [Abstract][Full Text] [Related]
12. In vitro mannosidase activity of EDEM3 against asparagine-linked oligomannose-type glycans.
Kikuma T; Ibuki H; Nakamoto M; Seko A; Ito Y; Takeda Y
Biochem Biophys Res Commun; 2022 Jul; 612():44-49. PubMed ID: 35500441
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
14. Restoration of the ATG5-dependent autophagy sensitizes DU145 prostate cancer cells to chemotherapeutic drugs.
Peng K; Sun A; Zhu J; Gao J; Li Y; Shao G; Yang W; Lin Q
Oncol Lett; 2021 Sep; 22(3):638. PubMed ID: 34386060
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
